2013年11月
TIPEPIDINE ACTIVATES VTA DOPAMINE NEURON VIA INHIBITING DOPAMINE D-2 RECEPTOR-MEDIATED INWARD RECTIFYING K+ CURRENT
NEUROSCIENCE
- ,
- ,
- ,
- 巻
- 252
- 号
- 開始ページ
- 24
- 終了ページ
- 34
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/j.neuroscience.2013.07.044
- 出版者・発行元
- PERGAMON-ELSEVIER SCIENCE LTD
We previously reported that the novel antidepressant-like effect of tipepidine may be produced at least partly through the activation of mesolimbic dopamine (DA) neurons via inhibiting G protein-coupled inwardly rectifying potassium (GIRK) channels. In this study, we investigated the action of tipepidine on DA D-2 receptor-mediated GIRK currents (I-DA(GIRK)) and membrane excitability in DA neurons using the voltage clamp and current clamp modes of the patch-clamp techniques, respectively. DA neurons were acutely dissociated from the ventral tegmental area (VTA) in rats and identified by the presence of the hyperpolarization-activated currents. Tipepidine reversibly inhibited I-DA(GIRK) with IC50 7.0 mu M and also abolished I-DA(GIRK) irreversibly activated in the presence of intracellular GTP gamma S. Then tipepidine depolarized membrane potential and generated action potentials in the neurons current-clamped. Furthermore, the drug at 40 mg/kg, i.p. increased the number of cells immunopositive both for c-Fos and tyrosine hydroxylase (TH) in the VTA. These results suggest that tipepidine may activate DA neurons in VTA through the inhibition of GIRK channel-activated currents. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.neuroscience.2013.07.044
- ISSN : 0306-4522
- eISSN : 1873-7544
- Web of Science ID : WOS:000325836000003